Background Outcomes of surgical trials hinge on surgeon selection and their underlying expertise. Assessment of expertise is paramount. We investigated whether surgeons' performance measured by the fundamentals of laparoscopic surgery (FLS) assessment program could predict their performance in a surgical trial. Methods As part of a prospective multi-institutional study of minimally invasive inguinal lymphadenectomy (MILND) for melanoma, surgical oncologists with no prior MILND experience underwent pre-trial FLS assessment. Surgeons completed MILND training, began enrolling patients, and submitted videos of each MILND case performed. Videos were scored with the global operative assessment of laparoscopic skills (GOALS) tool. Associations between baseline FLS scores and participant's trial performance metrics were assessed. Results Twelve surgeons enrolled patients; their median total baseline FLS score was 332 (range 275-380, max possible 500, passing [270). Participants enrolled 87 patients in the study (median 6 per surgeon, range 1-24), of which 72 (83%) videos were adequate for scoring. Baseline GOALS score was 17.1 (range 9.6-21.2, max possible score 30). Inter-rater reliability was excellent (ICC = 0.85). FLS scores correlated with improved GOALS scores (r = 0.57, p = 0.05) and with decreased operative time (r = -0.6, p = 0.02). No associations were found with the degree of patient recruitment (r = 0.02, p = 0.7), lymph node count (r = 0.01, p = 0.07), conversion rate (r = -0.06, p = 0.38) or major complications(r = -0.14, p = 0.6).
Abstract Background Outcomes of surgical trials hinge on surgeon selection and their underlying expertise. Assessment of expertise is paramount. We investigated whether surgeons' performance measured by the fundamentals of laparoscopic surgery (FLS) assessment program could predict their performance in a surgical trial. Methods As part of a prospective multi-institutional study of minimally invasive inguinal lymphadenectomy (MILND) for melanoma, surgical oncologists with no prior MILND experience underwent pre-trial FLS assessment. Surgeons completed MILND training, began enrolling patients, and submitted videos of each MILND case performed. Videos were scored with the global operative assessment of laparoscopic skills (GOALS) tool. Associations between baseline FLS scores and participant's trial performance metrics were assessed.
Results Twelve surgeons enrolled patients; their median total baseline FLS score was 332 (range 275-380, max possible 500, passing [270). Participants enrolled 87 patients in the study (median 6 per surgeon, range 1-24), of which 72 (83%) videos were adequate for scoring. Baseline GOALS score was 17.1 (range 9.6-21.2, max possible score 30). Inter-rater reliability was excellent (ICC = 0.85). FLS scores correlated with improved GOALS scores (r = 0.57, p = 0.05) and with decreased operative time (r = -0.6, p = 0.02). No associations were found with the degree of patient recruitment (r = 0.02, p = 0.7), lymph node count (r = 0.01, p = 0.07), conversion rate (r = -0.06, p = 0.38) or major complications(r = -0.14, p = 0.6).
Conclusions FLS skill assessment of surgeons prior to their enrollment in a surgical trial is feasible. Although better FLS scores predicted improved operative performance and operative time, other trial outcome measures showed no difference. Our findings have implications for the documentation of laparoscopic expertise of surgeons in practice and may allow more appropriate selection of surgeons to participate in clinical trials. Randomized controlled trials that compare the effectiveness of one surgical procedure over another depend greatly on comparable levels of expertise among participating surgeons. This concern was raised in the Veterans Affairs cooperative trial that compared open versus laparoscopic mesh-based inguinal hernia repairs, where an inferiority of the laparoscopic approach was encountered [1] . Critics have argued that participating surgeons' inexperience with the novel laparoscopic procedure led to an unfair comparison [2] . In contrast, the COST trial, which compared open versus laparoscopic colectomy for colon cancer and demonstrated non-inferiority for the laparoscopic approach, required participating surgeons to demonstrate procedural competency prior to enrollment in the trial [3] . The ability to assess, in a controlled environment, with a standardized, reliable and valid test, the operative skill of surgeons participating in clinical trials, without placing patients at risk would be invaluable for the design, implementation and success of surgical trials. Unfortunately, the assessment of operative skill is not straightforward. Multiple variables such as judgment, technical proficiency, patient and disease characteristics and operative team dynamics can interplay to affect the outcome of a surgical procedure. Nonetheless, given the recent advances in simulation-based education [4] , the assessment of operative skill through simulation has gained increased acceptance [5] . By far, the most studied approach to the assessment of basic laparoscopic skills has been the fundamentals of laparoscopic skill (FLS) program, which relies on five standardized simulation-based tasks to measure surgical skill outside of the operating room [6, 7] . FLS scores have been shown to be reliable and to predict intraoperative performance, both for surgeons in training and for those in practice [8] . In fact, passage of this test is required for graduating general surgery residents before they can sit for written and oral examinations by the American Board of Surgery. The aim of this study was to determine whether surgeons' performance, as measured by the FLS assessment program, could predict their performance in clinical practice as part of a surgical trial.
Methods
The Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection trial (SAFE-MILND, NCT01500304) is a prospective, multicenter, phase I/II clinical trial in which established melanoma surgeons were trained in a novel procedure, specifically the minimally invasive technique to perform an inguinal lymphadenectomy (MILND) [9, 10] . The primary aim of the trial was to evaluate the safety and feasibility of the MILND in the treatment of melanoma and have been previously published [9, 10] . For this manuscript, we focus on the pre-trial FLS assessment and the relationship of such with certain trial metrics as described below.
Surgeon recruitment, baseline skill assessment and MILND training
A select group of high-volume melanoma surgeons practicing in the USA who were all experienced in the conventional open inguinal lymphadenectomy (performing at least 6 per year), but had no previous MILND experience, were identified via their publication record and reputation. Surgeons were invited to participate in the SAFE-MILND trial and were required to attend an intense, hands-on, oneday training session to learn the innovative MILND procedure. Training sessions were standardized and occurred on two separate dates at Mayo Clinic, Rochester, Minnesota. Complete details of the training intervention have been previously published [9, 10] . Prior to any educational intervention, participants underwent baseline assessment of their basic laparoscopic skills with the FLS assessment program [6] . In brief, the FLS consists of five simulationbased assessment stations that include peg-transfer, circle pattern cutting, ligating loop application, intra-and extracorporeal knot tying. After a brief orientation of each task, participants were allowed a single acclimation attempt followed by one assessment attempt. Standard FLS scoring for certification purposes follows a proprietary system which is not publicly available. We scored the FLS by incorporating time, accuracy and errors as has been previously described by Vassiliou et al. [11] . In addition, although the FLS assessment program is also composed of a knowledge-based test, we elected not to include this in our assessment as our focus was on operative skill; the validity of the knowledge component is not as well established as that of its skill counterpart [8] .
After the baseline assessment, attendees watched an instructional video, depicting the MILND procedure in high-quality graphic detail and adhering to effective adult learning principles [12] . The 20-min video included a 3D animated component of the relevant anatomy with key steps of the procedure outlined and visually depicted, as well as a series of edited operative cases, highlighting the critical aspects of the procedure. The video can be seen at http:// medprofvideos.mayoclinic.org/videos/minimally-invasiveinguinal-lymph-node-dissection-milnd. All attendees then participated in a hands-on cadaveric laboratory in which each participant performed MILND in a controlled environment under instructional supervision, functioning as first assistant for one case and surgeon for one case. Each participant was given a DVD copy of the educational video to allow them to review the operation in detail as needed after the course.
Video review and assessment of operative performance
After obtaining institutional review board (IRB) approval, each surgeon prospectively enrolled patients and submitted all data to a central site. Participating surgeons were required to video-record all MILND cases performed throughout the study period. Videos were submitted to the central study site, where they were examined for quality and those deemed either incomplete or with poor graphics precluding adequate scoring were discarded. The first (baseline) and last MILND case videos were scored by two independent surgeon raters. Raters had prior MILND experience and laparoscopic expertise. The global operative assessment for laparoscopic surgery (GOALS) tool was used to score the video-recorded MILND operative performances [13] . GOALS is a global rating scale that measures performance in five domains: depth perception, bimanual dexterity, efficiency, tissue handling and autonomy. Each domain is rated on a 5-point Likert scale with descriptive anchors. The degree of case difficulty was assessed also using a 5-point Likert scale as described by Gumbs et al. [14] and incorporated into the GOALS score for a maximum possible score of 30 [15] . GOALS has been shown to demonstrate adequate inter-rater reliability, discriminate between different levels of expertise [16] and changes in GOALS scores after training have been associated with meaningful improvements in patient outcomes [15] . Raters were familiar with the use of the GOALS tool and received a brief pre-rating orientation. [17] . Change in GOALS score from first to last MILND case was evaluated with a paired t test. A random sample of 20% of the submitted videos was reviewed and scored in duplicate to calculate inter-rater reliability through intraclass correlation coefficients (ICC). ICC were classified based on Cohen's classification as large (C0.8), moderate (0.5-0.8) and small/ negligible (\0.5), with greater values indicating better interrater agreement [18] . All hypothesis testing was two-tailed, and a p value of B0.05 was considered statistically significant. Analyses were performed with JMP software (version 10, SAS Institute Inc., Cary, North Carolina).
Trial outcome measures
Operative time, lymph node harvest count, need for conversion to open inguinal lymph node dissection and occurrence of any major complication was calculated for each surgeon for their first (baseline) and last MILND case, as well as a respective average for all cases. Complications were graded using the National Cancer Institute's Common Terminology Criteria for Adverse Events (CTCAE version 4.0). Major complications were defined as those grade 3 (severe or medically significant but not immediately lifethreatening; hospitalization or prolongation of hospitalization indicated; disabling; limiting self-care and activities of daily living) or greater, excluding lymphedema and seroma.
Statistical analyses

Results
Sixteen surgeons from 12 institutions completed the FLS assessment and MILND training program. Thirteen surgeons from 10 institutions opened the IRB-approved trial at Surg Endosc (2017) 31:3313-3319 3315 their institution and 12 surgeons prospectively enrolled 88 patients to the trial between June 2012 and September 2014. One patient withdrew preoperatively, and 87 operative cases made up the study group. The median MILND procedures performed per participating surgeon were 6 with a range of 1-24. Median total FLS score was 332 (range 275-380, max possible 500). All participants achieved a passing score ([270) [19] , but only three surgeons (3/12, 25%) demonstrated skills previously shown to be comparable to expert laparoscopic surgeons ([350 on 500 point scale or 70 on 100 point scale) [16] .
We received 79 (91%) video submissions. Seven videos were discarded due to poor quality, yielding 72 (83%) videos adequate for operative performance scoring. Median baseline MILND operative performance (GOALS) score was 17.1 (range 9.6-21.2, max possible score 30). Interrater reliability was excellent (ICC = 0.85).
FLS scores correlated with baseline GOALS scores (r = 0.57, p = 0.05) and with baseline operative time (r = -0.6, p = 0.02), meaning that greater FLS scores were associated with improved operative performance and shorter operative time (Figs. 1, 2) during the first case. With regard to FLS scores, no associations were found with the degree of patient recruitment (r = 0.02, p = 0.7), average lymph node count (r = 0.01, p = 0.07), trial conversion rate (r = -0.06, p = 0.38) or average major complication rate (r = -0.14, p = 0.6).
There was no significant improvement in GOALS scores from the first to last MILND video submission (median 4 [IQR 2-8.5, range 0-22] procedures in between), with a mean ± SEM change in GOALS score of 2.7 ± 2, p = 0.2. Baseline FLS scores did not correlate (r = 0.36, p = 0.34) with change in GOALS scores from first to last MILND video submission.
Baseline GOALS scores correlated with baseline operative time (r = -0.6, p = 0.04) and average major complication rate (r = -0.58, p = 0.05, Fig. 3 ), meaning that improved operative performance on the first case was associated with fewer major complications over the duration of the trial and shorter operative times. However, GOALS scores (particularly scores from the last case) were not associated with degree of patient recruitment (r = -0.1, p = 0.72), average lymph node count (r = 0.01, p = 0.9) or with trial conversion rate (r = -0.24, p = 0.5).
Discussion
Our study demonstrates that FLS skill assessment of surgeons prior to their enrollment in a surgical trial is feasible. We also demonstrated better FLS scores predicted improved operative performance and decreased operative time; however, other outcome measures showed no This study adds to the validation argument of FLS as a tool for assessing basic laparoscopic skills of practicing surgeons in a simulated environment [8] . The overall FLS score correlated with outcomes that are clinically relevant such as operative performance and operative time. Other outcome measures such as surgical site infection and lymph node count are likely dependent on multiple factors, and a much larger study would be required to assess whether a participating surgeon's degree of basic laparoscopic skill impact these measures. The finding that GOALS scores were associated with certain trial outcomes also supports the use of such scoring systems for the assessment of laparoscopic skills of practicing surgeons in the clinical setting. Our study results are in line with the results of a recent systematic review of the simulation literature that has shown that simulation-based assessments often correlate with patient outcomes [20] . Nonetheless, the FLS assessment has its limitations. In this study, FLS did not correlate with several important clinical outcomes. This is not unexpected, as FLS scores are more of a proxy for basic laparoscopic skills and would reward speed and efficiency, hence our findings of shorter operative times in those with greater FLS scores. Future research should explore how other assessment instruments, perhaps more procedure specific tools, correlate with trial outcomes that are clinically relevant.
Historically, surgeon recruitment for surgical clinical trials has been akin to convenience sampling, where surgeons are invited to participate based on word of mouth, reputation or their scope of practice, with occasional review of case logs as a form of documenting expertise. Such an approach has compromised the study quality of some surgical clinical trials [1] . On the other hand, the COST trial required participating trial surgeons to submit 20 operative reports and one video-recording of their laparoscopic colectomies to demonstrate competency and adherence to oncologic standards [3] . However, no quantifiable assessment of their operative skill was performed. Being able to objectively quantify and assess the relationship between different degrees of operative skill and trial outcomes would be valuable to the design, implementation and monitoring of quality control measures in any surgical trial. This could be performed as a screening measure prior to trial participation, and if this video review could be performed in real time during the trial, then the potential for early identification of a poor performing surgeon with opportunity for targeted remediation would exist. This would be even more relevant to low volume, complex laparoscopic procedures, such as the MILND described in this report. The downside of this approach is trying to incorporate the success of clinical trials that are dependent on technical skills into broad clinical practice when the only participating surgeons that demonstrated efficacy of the procedure are high-volume individuals with a high degree of experience and technical prowess. Nonetheless, precedent for such efforts exist, the CREST trial which compared carotid endarterectomy versus endovascular stenting established a comprehensive training and credentialing process to select surgeons and interventionalists [21, 22] . Their rigorous selection process led them to narrow their recruitment from 427 applicants to 224 individuals with the skills required to ensure that the randomized trial results fairly contrasted outcomes between endarterectomy and stenting [21] .
Consistent with our previous report of the MILND trial [9] , where a significant learning curve was not appreciated, the operative performance scores (GOALS) in this study did not appear to significantly improve over subsequent MILND cases. This could be a reflection of the effectiveness of the pre-trial MILND training intervention, a learning curve that has not yet been reached, a wide variation in the number of procedures that each surgeon performed, our analyses were underpowered, or our assessment instruments or endpoints were not sensitive enough to detect a difference if one did exist.
Limitations
Our study has limitations that we acknowledge. Only short-term outcomes were evaluated, and as in any oncologic disease, poor surgical quality demonstrated by greater disease recurrence rates may require larger series and longer time to present itself. We encountered variation in the contribution of cases per surgeon, which could have biased our results to high-volume accruing surgeons; however, this was not possible to standardize and is reflective of clinical practice. Also, it was not possible for us to control the time between baseline FLS skill assessment and the time each surgeon performed their first MILND case; therefore, such time heterogeneity and the potential intervening gap in operative experience of each surgeon could have affected some of our results. In addition, not all participating surgeons were laparoscopically trained during residency or fellowship, and for some melanoma surgeons, laparoscopy makes up a very limited part of their standard practice; as such, diversity in baseline skill could be seen as a bias or strength in our study depending on the lens through which it is viewed. As noted, there are many components of the FLS test and we chose to only compare outcomes with the total FLS score. We did not perform sub-analysis on individual FLS tasks to identify whether one task correlated better with specific outcomes. Likewise, the MILND training intervention could have biased study results by adding additional MILND operative exposure to our surgical cohort between assessment time-points. We did not account for multiple hypothesis testing, and because we did not perform a formal power analysis, there is the possibility that some of our results are a type I statistical error. Nonetheless, we feel that the multi-institutional nature and prospective design of this project add strength to the reproducibility of our study findings.
Implications
Our study provides the first attempt at quantifying the degree of trial surgeons' basic laparoscopic skill set. We have demonstrated the feasibility and potential value of this approach; however, many questions remain unanswered and hence represent opportunity for further research in the field. For example, can the FLS pass/fail score threshold that is currently used as a benchmark for graduating general surgery residents be applied as an inclusion criteria for practicing surgeons being recruited for a surgical trial of a laparoscopic procedure? Would any of the individual FLS tasks be enough to predict certain trail outcomes and hence simplify the assessment? Can we use the FLS program to train participating surgeons to attain a more uniform performance level and achieve greater in-trial operative performance homogeneity? Can we develop an in-trial video review assessment process linked to a feedback mechanism that would give participating surgeons the opportunity to remediate or perform corrective actions before accruing further patients?
Conclusions
In summary, the assessment of operative skill through simulation has become commonplace in the education of surgical trainees and is beginning to find a role in the assessment of practicing surgeons. Our study results suggest that the assessment of practicing surgeon's skills via FLS, prior to their enrollment in a surgical trial, is feasible and represents a valuable opportunity to potentially improve the quality of surgical clinical trials.
